Intended for healthcare professionals
DIGITAL SOLUTIONS

Innovations in diagnosis and management of skin cancers and suspicious lesions – what is the place for digital solutions in today's cancer pathways?

 

Jonathan Kentley, MBBS BSc MSc MRCP Dermatology Registrar Imperial College NHS Trust

Lucy Thomas, MPharm MBChB MRCP (Derm) Consultant Dermatologist Chelsea and Westminster Hospital NHS Foundation Trust

Claire Fuller, MA FRCP Consultant Dermatologist Chair of International Foundation for Dermatology Chelsea and Westminster Hospital NHS Foundation Trust

Melanoma is the fifth most common cancer in the UK, and incidence is predicted to rise by 7% between 2017- 2035.1 Non-melanoma skin cancer (NMSC), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), is the most common cancer in the UK with an estimated 155,985 cases in the UK from 2016-2018, representing a 169% increase from the early 1990s.2

Dermatology in practice 2022; 28(2): 32–35
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)